FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056545932> ?p ?o ?g. }

• W2056545932 endingPage "e13416" @default.
• W2056545932 startingPage "e13416" @default.
• W2056545932 abstract "Background The use of TNF inhibitors has been a major progress in the treatment of chronic inflammation. However, not all patients respond. In addition, response will be often lost when treatment is stopped. These clinical aspects indicate that other cytokines might be involved and we focus here on the role of IL-17. In addition, the chronic nature of joint inflammation may contribute to reduced response and enhanced chronicity. Therefore we studied the capacity of IL-17 to regulate synoviolin, an E3 ubiquitin ligase implicated in synovial hyperplasia in human rheumatoid arthritis (RA) FLS and in chronic reactivated streptococcal cell wall (SCW)-induced arthritis. Methodology/Principal Findings Chronic reactivated SCW-induced arthritis was examined in IL-17R deficient and wild-type mice. Synoviolin expression was analysed by real-time RT-PCR, Western Blot or immunostaining in RA FLS and tissue, and p53 assessed by Western Blot. Apoptosis was detected by annexin V/propidium iodide staining, SS DNA apoptosis ELISA kit or TUNEL staining and proliferation by PCNA staining. IL-17 receptor A (IL-17RA), IL-17 receptor C (IL-17-RC) or synoviolin inhibition were achieved by small interfering RNA (siRNA) or neutralizing antibodies. IL-17 induced sustained synoviolin expression in RA FLS. Sodium nitroprusside (SNP)-induced RA FLS apoptosis was associated with reduced synoviolin expression and was rescued by IL-17 treatment with a corresponding increase in synoviolin expression. IL-17RC or IL-17RA RNA interference increased SNP-induced apoptosis, and decreased IL-17-induced synoviolin. IL-17 rescued RA FLS from apoptosis induced by synoviolin knockdown. IL-17 and TNF had additive effects on synoviolin expression and protection against apoptosis induced by synoviolin knowndown. In IL-17R deficient mice, a decrease in arthritis severity was characterized by increased synovial apoptosis, reduced proliferation and a marked reduction in synoviolin expression. A distinct absence of synoviolin expressing germinal centres in IL-17R deficient mice contrasted with synoviolin positive B cells and Th17 cells in synovial germinal centre-like structures. Conclusion/Significance IL-17 induction of synoviolin may contribute at least in part to RA chronicity by prolonging the survival of RA FLS and immune cells in germinal centre reactions. These results extend the role of IL-17 to synovial hyperplasia." @default.
• W2056545932 created "2016-06-24" @default.
• W2056545932 creator A5016322649 @default.
• W2056545932 creator A5021836140 @default.
• W2056545932 creator A5024908446 @default.
• W2056545932 creator A5024916892 @default.
• W2056545932 creator A5037812104 @default.
• W2056545932 creator A5042948779 @default.
• W2056545932 creator A5045199963 @default.
• W2056545932 creator A5045215696 @default.
• W2056545932 creator A5061856328 @default.
• W2056545932 creator A5078788580 @default.
• W2056545932 date "2010-10-15" @default.
• W2056545932 modified "2023-09-23" @default.
• W2056545932 title "Role of Interleukin 17 in Arthritis Chronicity through Survival of Synoviocytes via Regulation of Synoviolin Expression" @default.
• W2056545932 cites W1480160648 @default.
• W2056545932 cites W1504496748 @default.
• W2056545932 cites W1971944674 @default.
• W2056545932 cites W1975204978 @default.
• W2056545932 cites W1986440453 @default.
• W2056545932 cites W1991188836 @default.
• W2056545932 cites W1993328396 @default.
• W2056545932 cites W1993964409 @default.
• W2056545932 cites W1995246332 @default.
• W2056545932 cites W1999124126 @default.
• W2056545932 cites W2010042266 @default.
• W2056545932 cites W2021674244 @default.
• W2056545932 cites W2024644107 @default.
• W2056545932 cites W2026190214 @default.
• W2056545932 cites W2032731042 @default.
• W2056545932 cites W2035936653 @default.
• W2056545932 cites W2045151558 @default.
• W2056545932 cites W2047977555 @default.
• W2056545932 cites W2073266561 @default.
• W2056545932 cites W2074438676 @default.
• W2056545932 cites W2078265535 @default.
• W2056545932 cites W2081025997 @default.
• W2056545932 cites W2092569546 @default.
• W2056545932 cites W2096931514 @default.
• W2056545932 cites W2097868610 @default.
• W2056545932 cites W2102909249 @default.
• W2056545932 cites W2107235439 @default.
• W2056545932 cites W2110031819 @default.
• W2056545932 cites W2114180142 @default.
• W2056545932 cites W2115631255 @default.
• W2056545932 cites W2116856042 @default.
• W2056545932 cites W2152348310 @default.
• W2056545932 cites W2153983398 @default.
• W2056545932 cites W2155779547 @default.
• W2056545932 cites W2160731095 @default.
• W2056545932 cites W2167107736 @default.
• W2056545932 cites W2171513671 @default.
• W2056545932 cites W2171571685 @default.
• W2056545932 doi "https://doi.org/10.1371/journal.pone.0013416" @default.
• W2056545932 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/2955522" @default.
• W2056545932 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20976214" @default.
• W2056545932 hasPublicationYear "2010" @default.
• W2056545932 type Work @default.
• W2056545932 sameAs 2056545932 @default.
• W2056545932 citedByCount "79" @default.
• W2056545932 countsByYear W20565459322012 @default.
• W2056545932 countsByYear W20565459322013 @default.
• W2056545932 countsByYear W20565459322014 @default.
• W2056545932 countsByYear W20565459322015 @default.
• W2056545932 countsByYear W20565459322016 @default.
• W2056545932 countsByYear W20565459322017 @default.
• W2056545932 countsByYear W20565459322018 @default.
• W2056545932 countsByYear W20565459322019 @default.
• W2056545932 countsByYear W20565459322020 @default.
• W2056545932 countsByYear W20565459322021 @default.
• W2056545932 countsByYear W20565459322022 @default.
• W2056545932 countsByYear W20565459322023 @default.
• W2056545932 crossrefType "journal-article" @default.
• W2056545932 hasAuthorship W2056545932A5016322649 @default.
• W2056545932 hasAuthorship W2056545932A5021836140 @default.
• W2056545932 hasAuthorship W2056545932A5024908446 @default.
• W2056545932 hasAuthorship W2056545932A5024916892 @default.
• W2056545932 hasAuthorship W2056545932A5037812104 @default.
• W2056545932 hasAuthorship W2056545932A5042948779 @default.
• W2056545932 hasAuthorship W2056545932A5045199963 @default.
• W2056545932 hasAuthorship W2056545932A5045215696 @default.
• W2056545932 hasAuthorship W2056545932A5061856328 @default.
• W2056545932 hasAuthorship W2056545932A5078788580 @default.
• W2056545932 hasBestOaLocation W20565459321 @default.
• W2056545932 hasConcept C104317684 @default.
• W2056545932 hasConcept C190283241 @default.
• W2056545932 hasConcept C196795494 @default.
• W2056545932 hasConcept C203014093 @default.
• W2056545932 hasConcept C204232928 @default.
• W2056545932 hasConcept C22615655 @default.
• W2056545932 hasConcept C2775934118 @default.
• W2056545932 hasConcept C2776415932 @default.
• W2056545932 hasConcept C2776914184 @default.
• W2056545932 hasConcept C2777077863 @default.
• W2056545932 hasConcept C2778690821 @default.
• W2056545932 hasConcept C31573885 @default.
• W2056545932 hasConcept C502942594 @default.
• W2056545932 hasConcept C54009773 @default.

• next